PREVENAR

This brand name is authorized in Estonia, Ireland, Lithuania, South Africa

Active ingredients

The drug PREVENAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Pneumococcus antigen, serotype 4 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

2 Pneumococcus antigen, serotype 6B UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

3 Pneumococcus antigen, serotype 9V UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

4 Pneumococcus antigen, serotype 14 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

5 Pneumococcus antigen, serotype 18C UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

6 Pneumococcus antigen, serotype 19F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

7 Pneumococcus antigen, serotype 23F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AL02	Pneumococcus, purified polysaccharides antigen conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines
Discover more medicines within J07AL02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1012767, 1063202, 1063235, 1063246, 1368187
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007899, 1007900, 1008542, 1008543, 1030399, 1030400, 1030401, 1033099
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/30.1/0239